Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Westhafen Intercontinental Grp"'
Autor:
Bader, P., Salzmann-Manrique, E., Balduzzi, A., Dalle, J.H., Woolfrey, A.E., Bar, M., Verneris, M.R., Borowitz, M.J., Shah, N.N., Gossai, N., Shaw, P.J., Chen, A.R., Schultz, K.R., Kreyenberg, H., Maio, L. di, Cazzaniga, G., Eckert, C., Velden, V.H.J. van der, Sutton, R., Lankester, A., Peters, C., Klingebiel, T.E., Willasch, A.M., Grupp, S.A., Pulsipher, M.A., Children's Oncology Grp, Pediatric Blood Marrow Transplant, Australian Transplantation Grp, Int Berlin-Frankfurt-Munster St, European Soc Blood Marrow Transpl, Westhafen Intercontinental Grp
Publikováno v:
Blood advances, 3(21), 3393-3405. American Society of Hematology
Blood Advances, 3(21), 3393-3405. AMER SOC HEMATOLOGY
Blood Advances, 3(21), 3393-3405. AMER SOC HEMATOLOGY
Detection of minimal residual disease (MRD) pre- and post-hematopoietic cell transplantation (HCT) for pediatric acute lymphoblastic leukemia (ALL) has been associated with relapse and poor survival. Published studies have had insufficient numbers to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::374ea6149f2e7aa55b8c424e8b31d0bd
https://hdl.handle.net/1887/121740
https://hdl.handle.net/1887/121740
Autor:
Lankester, A.C., Locatelli, F., Bader, P., Rettinger, E., Egeler, M., Katewa, S., Pulsipher, M.A., Nierkens, S., Schultz, K., Handgretinger, R., Grupp, S.A., Boelens, J.J., Bollard, C.M., Westhafen Intercontinental Grp
Publikováno v:
Biology of Blood and Marrow Transplantation, 21(3), 402. Elsevier Inc.
Biology of Blood and Marrow Transplantation, 21(3), 402-411
Biology of Blood and Marrow Transplantation, 21(3), 402-411
Although allogeneic hematopoietic stem cell transplantation (HSCT) is a curative approach for many pediatric patients with hematologic malignancies and some nonmalignant disorders, some critical obstacles remain to be overcome, including relapse, eng
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::323ffcb843a005e470a3e444e73a0c69
https://dspace.library.uu.nl/handle/1874/331384
https://dspace.library.uu.nl/handle/1874/331384
Autor:
Nierkens, S., Lankester, A.C., Egeler, R.M., Bader, P., Locatelli, F., Pulsipher, M.A., Bollard, C.M., Boelens, J.J., Westhafen Intercontinental Grp
Publikováno v:
Cytotherapy, 17(12), 1667. Informa Healthcare
Cytotherapy, 17(12), 1667-1674
Cytotherapy, 17(12), 1667-1674
Clinical trials aimed at improving results of hematopoietic cell transplantation (HCT) by adjuvant cell-based interventions in children have been limited by small numbers and pediatric-specific features. The need for a larger number of pediatric HCT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fcf9928eb19160ab41759afd190067e
https://hdl.handle.net/10807/228568
https://hdl.handle.net/10807/228568